URBN
55
-11
SYY
41
-6
ECL
59
-3
FE
41
-3
IBM
50
-3
XRAY
23
3
VMC
59
-4
PSA
55
-3
AA
41
3
HSIC
42
-3
FLR
50
2
CRM
69
-6
HRL
39
9
LH
46
-4
ADT
55
-3
HSY
38
-5
CSX
62
-6
FDX
44
-10
ILMN
42
-3
TAP
60
-4
URBN
55
-11
SYY
41
-6
ECL
59
-3
FE
41
-3
IBM
50
-3
XRAY
23
3
VMC
59
-4
PSA
55
-3
AA
41
3
HSIC
42
-3
FLR
50
2
CRM
69
-6
HRL
39
9
LH
46
-4
ADT
55
-3
HSY
38
-5
CSX
62
-6
FDX
44
-10
ILMN
42
-3
TAP
60
-4
Financhill
Back

Plus Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
35

PSTV
Plus Therapeutics

Last Price:
1.26
Seasonality Move:
1.66%
Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Sell
35
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy, Sell or Hold?

  • The current Plus Therapeutics [PSTV] share price is $1.26. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $8.92. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSTV Stock Price Chart

What is Plus Therapeutics's stock price today?

  • The Plus Therapeutics share price today is $1.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $8.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

PSTV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 43.13 Sell
Chaikin Money Flow: -55507 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 1.41) Sell
Bollinger Bands (100): (1.32 - 1.68) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 23.03 Sell
Chaikin Money Flow: -1324869 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.92 - 12.78) Sell
Bollinger Bands (100): (11.21 - 14.35) Sell

PSTV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.3 Sell
20-day SMA: 1.34 Sell
50-day SMA: 1.4 Sell
200-day SMA: 1.72 Sell
8-day EMA: 1.29 Sell
20-day EMA: 1.33 Sell
50-day EMA: 1.4 Sell
200-day EMA: 1.76 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.04 Sell
20-day SMA: 11.63 Sell
50-day SMA: 12.76 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.64 Sell
20-day EMA: 11.47 Sell
50-day EMA: 12.32 Sell
200-day EMA: 11.71 Sell

Plus Therapeutics Earnings Growth & PSTV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.25 per share.

Plus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):